These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32408197)

  • 81. Beneficial effect of polyclonal immunoglobulins from malaria-infected BALB/c mice on the lupus-like syndrome of (NZB x NZW)F1 mice.
    Hentati B; Sato MN; Payelle-Brogard B; Avrameas S; Ternynck T
    Eur J Immunol; 1994 Jan; 24(1):8-15. PubMed ID: 8020574
    [TBL] [Abstract][Full Text] [Related]  

  • 82. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
    Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
    [TBL] [Abstract][Full Text] [Related]  

  • 83. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
    Chalmers SA; Glynn E; Garcia SJ; Panzenbeck M; Pelletier J; Dimock J; Seccareccia E; Bosanac T; Khalil S; Harcken C; Webb D; Nabozny G; Fine JS; Souza D; Klein E; Herlitz L; Ramanujam M; Putterman C
    Clin Immunol; 2018 Dec; 197():205-218. PubMed ID: 30339790
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Defects in the structure and expression of the genes for the T cell marker Rt6 in NZW and (NZB x NZW)F1 mice.
    Koch-Nolte F; Klein J; Hollmann C; Kühl M; Haag F; Gaskins HR; Leiter E; Thiele HG
    Int Immunol; 1995 May; 7(5):883-90. PubMed ID: 7547715
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice.
    Sitrin J; Suto E; Wuster A; Eastham-Anderson J; Kim JM; Austin CD; Lee WP; Behrens TW
    J Immunol; 2017 Aug; 199(4):1238-1249. PubMed ID: 28696253
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Immunologic abnormality in NZB/NZW F1 mice. Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of the athymic nude individuals.
    Mihara M; Ohsugi Y; Saito K; Miyai T; Togashi M; Ono S; Murakami S; Dobashi K; Hirayama F; Hamaoka T
    J Immunol; 1988 Jul; 141(1):85-90. PubMed ID: 3259971
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Treatment with a CD40 Antagonist Antibody Reverses Severe Proteinuria and Loss of Saliva Production and Restores Glomerular Morphology in Murine Systemic Lupus Erythematosus.
    Perper SJ; Westmoreland SV; Karman J; Twomey R; Seagal J; Wang R; McRae BL; Clarke SH
    J Immunol; 2019 Jul; 203(1):58-75. PubMed ID: 31109957
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The treatment of autoimmune disease in (NZB/NZW)F1 mice with syngeneic photomodulated splenocytes.
    Lin RH; Wang LF
    Scand J Immunol; 1994 May; 39(5):446-52. PubMed ID: 8191220
    [TBL] [Abstract][Full Text] [Related]  

  • 89. DNA vaccine encoding heat shock protein 90 protects from murine lupus.
    Liu A; Shi FD; Cohen IR; Castaldo G; Matarese G; Quintana FJ; La Cava A
    Arthritis Res Ther; 2020 Jun; 22(1):152. PubMed ID: 32571400
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Defective in vitro IL-2 production in lupus is an early but secondary event paralleling disease activity: evidence from the murine parent-into-F1 model supports staging of IL-2 defects in human lupus.
    Via CS; Shearer GM
    Autoimmunity; 2010 Feb; 43(1):23-31. PubMed ID: 20001649
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Spontaneous autoimmune disease in (NZB x NZW)F1 mice is ameliorated by treatment with methimazole.
    Mozes E; Zinger H; Kohn LD; Singer DS
    J Clin Immunol; 1998 Mar; 18(2):106-13. PubMed ID: 9533654
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Genetically determined aberrant down-regulation of FcgammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus.
    Jiang Y; Hirose S; Sanokawa-Akakura R; Abe M; Mi X; Li N; Miura Y; Shirai J; Zhang D; Hamano Y; Shirai T
    Int Immunol; 1999 Oct; 11(10):1685-91. PubMed ID: 10508186
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB X NZW)F1 hybrid and the correlation to renal disease.
    Maruyama N; Furukawa F; Nakai Y; Sasaki Y; Ohta K; Ozaki S; Hirose S; Shirai T
    J Immunol; 1983 Feb; 130(2):740-6. PubMed ID: 6217253
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cyclophosphamide and 15(S)-15 methyl PGE1 correct the T/B lymphocyte ratios of NZB/NZW mice.
    Girard D; Aloisi RM; Bliven ML; Cunningham AC; Otterness IG
    Agents Actions; 1990 Mar; 29(3-4):333-41. PubMed ID: 2339673
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Murine lupus susceptibility locus Sle1a requires the expression of two sub-loci to induce inflammatory T cells.
    Cuda CM; Zeumer L; Sobel ES; Croker BP; Morel L
    Genes Immun; 2010 Oct; 11(7):542-53. PubMed ID: 20445563
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE.
    Puliaeva I; Puliaev R; Via CS
    Autoimmun Rev; 2009 Jan; 8(3):219-23. PubMed ID: 18725326
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Intrinsic hyporesponsiveness of invariant natural killer T cells precedes the onset of lupus.
    Yang JQ; Kim PJ; Halder RC; Singh RR
    Clin Exp Immunol; 2013 Jul; 173(1):18-27. PubMed ID: 23607366
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Reduction of Cell Surface T-Cell Receptor by Non-Mitogenic CD3 Antibody to Mitigate Murine Lupus.
    Morita M; Mizui M; Masuyama S; Tsokos GC; Isaka Y
    Front Immunol; 2022; 13():855812. PubMed ID: 35419004
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Intestinal permeability and inflammatory features of juvenile age correlate with the eventual systemic autoimmunity in lupus-prone female SWR × NZB F1 (SNF1) mice.
    Gudi RR; Johnson BM; Gaudreau MC; Sun W; Ball L; Vasu C
    Immunology; 2024 Feb; 171(2):235-249. PubMed ID: 37947218
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Disparate effects of depletion of CD1d-reactive T cells during early versus late stages of disease in a genetically susceptible model of lupus.
    Jacinto J; Kim PJ; Singh RR
    Lupus; 2012 Apr; 21(5):485-90. PubMed ID: 22065098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.